Search

everythinglearnresearchcommunity

for

Search:↓

Stigmatization and quality of life in people with alopecia are influenced by gender and sociodemographics, suggesting a need for better support.

Interleukin levels are higher in alopecia areata patients but don't predict disease severity or duration.

Higher MIF levels in alopecia areata patients suggest it could be a treatment target and disease predictor.

Treat alopecia areata with personalized plans, using corticosteroids for mild cases and Janus Kinase inhibitors for severe cases, while also offering psychological support.

Alopecia areata patients may have higher cardiovascular risk factors, so screening for metabolic syndrome components is suggested.

Topical metformin gel is as effective and safe as steroids for treating alopecia areata.

Both treatments work equally well for hair regrowth, but the lotion has fewer side effects.

Baricitinib is effective for treating severe alopecia areata in Japanese patients, but long-term safety needs more study.

Alopecia Areata severely impacts mental health, causing anxiety and depression, affecting quality of life.

Baricitinib treatment helps regrow eyebrow, eyelash, and scalp hair in severe alopecia areata, improving patients' emotional well-being and quality of life.

Bimatoprost and clobetasol are both effective for scalp hair loss, but bimatoprost works faster, has fewer side effects, and grows more colored hair.

People with alopecia areata had lower vitamin D levels, but these levels did not relate to how severe their condition was.

Alopecia Areata (AA) causes significant emotional distress, including feelings of embarrassment, depression, and anxiety, and impacts social interactions and daily activities.

Tofacitinib helped regrow hair in patients with alopecia, with few side effects.

New JAK inhibitor drugs show promise for treating skin diseases but need more research on safety and effectiveness.

The article concludes that different types of hair loss require specific treatments and psychological support is important.

Low levels of BDNF and vitamin D are linked to higher depression in alopecia areata and vitiligo patients.

Alopecia areata is linked to PTSD, alcohol use, anxiety, and depression.

Hair regrowth in Alopecia Areata patients leads to increased satisfaction and reduced stress.

Yellow dots and short vellus hairs are the most common signs of Alopecia Areata (AA), and trichoscopy can help diagnose AA and track treatment progress.

The combination of vitamin D analogues with potent steroids is a favorable treatment for alopecia areata with fewer side effects.

Alopecia areata may be linked to heart issues.

Both azathioprine and betamethasone treatments effectively regrow hair in alopecia areata, but azathioprine may be safer.

High levels of HSP70 and IL-15 are linked to more severe alopecia areata.

AI can effectively detect hair and scalp disorders from images.

JAK inhibitors show promise for treating alopecia areata but have serious side effects.

Oral betamethasone mini-pulses effectively treat moderate to severe alopecia areata with manageable side effects.

Baricitinib effectively promotes regrowth of eyebrows and eyelashes in alopecia areata patients.

JAK inhibitors effectively regrow hair in children with alopecia areata and are safe to use.

A new classification and scoring system is needed for alopecia areata to better assess severity.